N., & Reddy, P
When combined (as in the investigational drug CagriSema ), they show promising synergistic effects for greater weight loss than either drug alone
Regular follow-up appointments allow us to track your progress and make any necessary adjustments to your treatment plan
For the wider research view, see the Cagrilintide guide on how it works, study results, side effects, and legal status
Metabolic health has become central to long-term wellness, and two compounds are generating significant attention: semaglutide, a prescription GLP-1 receptor agonist, and berberine, a plant alkaloid with centuries of traditional use
As of early 2026, GLP-1 receptor agonists have treated tens of millions worldwide ( [153] ), and that number is rapidly growing as new indications expand